GlycoFi in Merck alliance

December 14, 2005

NH Business Review Staff,

Lebanon-based GlycoFi has established a strategic alliance and multi-year research collaboration with Merck & Co. Inc., the pharmaceutical giant, that will focus on he use of GlycoFi’s yeast-based glycoprotein optimization platform to develop biologic and vaccine drug candidates.

The companies said GlycoFi and Merck scientists will work together to deploy GlycoFi’s technology to produce and optimize various pharmaceutical properties of a broad range of Merck’s biologic drug candidates, including vaccines, antibodies, and other therapeutic proteins.

Under the terms of the agreement, Merck will make an up-front cash payment and an equity investment in GlycoFi and fund GlycoFi’s research efforts.

GlycoFi is a venture-backed, biotechnology company whose investors include Polaris Venture Partners, SV Life Sciences, Boston Millennia Partners and Fletcher Spaght Ventures. – NHBR STAFF

Categories: News

More news from NHBR:

'From the Battlefield to the Boardroom' with Robert Campbell

Author, leadership coach and veteran of 27 years in the Army, Robert Campbell speaks on his 'Battlefield to Boardroom' book series and how companies can become veteran-ready

Live-work-create tech village eyed for Manchester

A tech-entrepreneur turned venture capitalist is eyeing one of the largest undeveloped tracts in Manchester for a community where tech- and startup-minded people would live and work. Freedom Village would be located on 250 acres of mostly wooded land at Hackett Hill, which is located in the northwestern corner of Manchester.

NHBR About Town: Week of October 9, 2026

Business and event happenings around the state of NH

Manchester property values jump nearly 50%

The value of all property in Manchester increased by almost half — 48% ‑ over the past five years, according to preliminary data released by city officials on Oct. 13 The valuations, compiled due to a citywide revaluation, add up to $23.09 billion. The current value of city properties is $15.56 billion, which was based on assessments made during the city's last revaluation.